APA (7th ed.) Citation

Antonijoan, R., García-Gea, C., Puntes, M., Pérez, J., Esbrí, R., Serra, C., . . . Barbanoj, M. J. (2007). Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): A randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults. Clinical therapeutics, 29(5), 814-822. https://doi.org/10.1016/j.clinthera.2007.05.001

Chicago Style (17th ed.) Citation

Antonijoan, Rosa, Consuelo García-Gea, Montserrat Puntes, Joselin Pérez, Ramón Esbrí, Cristina Serra, Josep Fortea, and Manuel J. Barbanoj. "Comparison of Inhibition of Cutaneous Histamine Reaction of Ebastine Fast-dissolving Tablet (20 Mg) Versus Desloratadine Capsule (5 Mg): A Randomized, Double-blind, Double-dummy, Placebo-controlled, Three-period Crossover Study in Healthy, Nonatopic Adults." Clinical Therapeutics 29, no. 5 (2007): 814-822. https://doi.org/10.1016/j.clinthera.2007.05.001.

MLA (9th ed.) Citation

Antonijoan, Rosa, et al. "Comparison of Inhibition of Cutaneous Histamine Reaction of Ebastine Fast-dissolving Tablet (20 Mg) Versus Desloratadine Capsule (5 Mg): A Randomized, Double-blind, Double-dummy, Placebo-controlled, Three-period Crossover Study in Healthy, Nonatopic Adults." Clinical Therapeutics, vol. 29, no. 5, 2007, pp. 814-822, https://doi.org/10.1016/j.clinthera.2007.05.001.